Peter Cox

VP Drug Discovery

Peter is VP of drug discovery leading a multidisciplinary team using AI/ML in conjunction with traditional drug discovery approaches to identify treatments for neurodegenerative diseases, inflammation and glioblastoma. Before joining BenevolentAI, Peter spent 16 years at Pfizer in preclinical drug discovery, leading and supporting projects targeting ion channels, enzymes, transporters and G-protein coupled receptors for the treatment of chronic pain. Peter completed postdoctoral training in neuroscience at INSERM, France and the University of Cambridge and obtained a PhD in Virology from the University of Glasgow.